Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 59 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

12%

7 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

16 recruiting

Enrollment Performance

Analytics

Phase 2
25(51.0%)
N/A
13(26.5%)
Phase 3
5(10.2%)
Phase 1
4(8.2%)
Phase 4
2(4.1%)
49Total
Phase 2(25)
N/A(13)
Phase 3(5)
Phase 1(4)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (59)

Showing 20 of 59 trials
NCT06554301Phase 1Recruiting

A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension

Role: collaborator

NCT06018493Not ApplicableCompleted

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE-HTN-II)

Role: collaborator

NCT05149365Phase 3Completed

Sitagliptin for Prevention of aGVHD After Alternative Donor Transplation

Role: collaborator

NCT07311772Phase 3Recruiting

Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid

Role: collaborator

NCT05657639Phase 2Recruiting

CAV Regimen for R/R AML

Role: collaborator

NCT06118034Phase 3Recruiting

Effect of Colchicine on Perioperative Anti-inflammatory Organ Injury in Cardiac Surgery

Role: collaborator

NCT03649503Recruiting

The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China

Role: collaborator

NCT06943729Recruiting

Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms

Role: collaborator

NCT06867991Phase 3Recruiting

Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis

Role: lead

NCT06078930Recruiting

Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms

Role: collaborator

NCT06950242Not ApplicableEnrolling By Invitation

Clinical Trial of Safety and Efficacy of Intracranial Laser Balloon Dilation Catheter in Patients With Symptomatic Intracranial Atherosclerotic Stenosis: A Prospective, Multi-center, Randomized Comparison

Role: lead

NCT06618222Completed

Wingspan Stent System for Intracranial Artery Stenosis

Role: lead

NCT06292585Not ApplicableRecruiting

Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT)

Role: collaborator

NCT04517214Phase 2Active Not Recruiting

Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma

Role: collaborator

NCT06331923Not ApplicableRecruiting

Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients with Diabetes

Role: collaborator

NCT06702657Not ApplicableNot Yet Recruiting

A Randomized Clinical Trial on Urgent Angioplasty for IntraCranial Atherosclerotic Stenosis-related Large-Vessel Occlusion After Mechanical Thrombectomy

Role: collaborator

NCT06456515Not ApplicableRecruiting

Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC

Role: lead

NCT06762782Phase 2Recruiting

Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery

Role: collaborator

NCT04992026Phase 2Completed

The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer

Role: collaborator

NCT06394674Phase 2Recruiting

High-dose Furmonertinib in the Treatment in Patients With Advanced, Metastatic NSCLC With Progressed After First- or Second-line Treatment With Osimertinib

Role: collaborator